Reimagine what's essential.
Refocus what's attainable.
Rethink what's possible.

As our world continues to change in the midst of the global COVID-19 pandemic, we have a profound opportunity to shift the infectious disease paradigm—and a vital responsibility to lead the charge.

It's time to counter confusion with clarity.

Introducing the Infectious Disease Council.

An international coalition of interdisciplinary experts representing the fields of pandemic infectious disease policy, healthcare, education, medical diagnostics and testing, and law have formed the InfectiousDisease Council to help organizations and individuals strike back against COVID-19.

Work Smart. Work Safe. Work Well.

Will a COVID-19 vaccine booster be necessary?

The short answer is most likely yes, a COVID-19 vaccine booster will eventually be necessary. There are two reasons that a booster shot may be required. The first is that our body’s immune response, which is primed either from previous infection or from vaccination, may wane over time. A booster may be required to amplify…

Will we need a COVID-19 vaccine booster?

As of May 2021, more than 160 million Americans have received at least one dose of a COVID-19 vaccine. The vaccines are shown to be highly effective in preventing infection in trials and in populations living in real–world conditions (Thompson et al. 2021). We do not yet know how long protection will last but recent…

Creating an Employee COVID-19 Vaccination Requirement: A Risk-Management Endeavor

Since the onset of the COVID-19 pandemic, the estimated direct financial costs to U.S. businesses from employees who have suffered from COVID-19 have been staggering: $50.5 billion, including $10.7 billion in disability wage payments, $15.5 billion in sick leave wages, and $22.7 billion in employee benefits as of April 2021 (Integrated Benefits Institute). These projections…
African American man in antiviral mask gesturing thumb up during coronavirus vaccination, approving of covid-19 immunization. Young doctor giving vaccine injection to male patient

COVID-19 Vaccination: When Will the U.S. Reach Herd Immunity?

Three COVID-19 vaccines produced by Pfizer, Moderna and Johnson & Johnson have all received emergency use authorization in the United States and a mass vaccination program is now underway. The vaccines are all very safe and effective, and as of the beginning of April 2021 more than 108 million people have received at least one…
Herd immunity of most people of population protecting all against virus concept visualized with geometrical hexagon grid background 3D rendering

How do we reach herd immunity?

Herd immunity is population–level protection against the spread of an infectious disease that is based on pre–existing immunity of a high proportion of individuals in that population, either from prior infection or vaccination. The idea of herd immunity also acknowledges the need to protect a small proportion of our population who cannot be vaccinated for…
A female medical student attending a school lecture raises her hand to ask a question. The multi-ethnic group of adult students is wearing medical scrubs and protective face masks to prevent viral infection during the Covid-19 pandemic.

Risk of Coronavirus Transmission in Classrooms, Clinical Settings, and the Community

Many colleges are reopening for in–person learning after major shutdowns during the spring and fall of 2020 to mitigate transmission of the novel coronavirus. Reopening is especially important for nursing education because there is already a substantial nurse shortage both in the United States and globally (Snavely 2016). An important question is whether nurses and…